CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $116,000 | -29.7% | 57,437 | -5.6% | 0.05% | -16.1% |
Q4 2021 | $165,000 | +1.9% | 60,836 | +67.1% | 0.06% | -12.7% |
Q3 2021 | $162,000 | -27.0% | 36,410 | -4.9% | 0.07% | -22.0% |
Q2 2021 | $222,000 | -56.0% | 38,303 | -55.7% | 0.09% | -65.5% |
Q3 2020 | $504,000 | -5.6% | 86,459 | +9.2% | 0.26% | +4.3% |
Q2 2020 | $534,000 | +83.5% | 79,177 | +73.0% | 0.25% | +110.8% |
Q1 2020 | $291,000 | -43.7% | 45,754 | -7.8% | 0.12% | +41.2% |
Q4 2019 | $517,000 | +146.2% | 49,615 | -7.3% | 0.08% | +102.4% |
Q3 2019 | $210,000 | -77.4% | 53,505 | -14.4% | 0.04% | -78.6% |
Q2 2019 | $930,000 | +67.6% | 62,509 | +102.5% | 0.20% | +106.3% |
Q4 2018 | $555,000 | +10.6% | 30,876 | +80.6% | 0.10% | +82.7% |
Q3 2018 | $502,000 | -30.7% | 17,101 | +7.4% | 0.05% | -91.9% |
Q2 2018 | $724,000 | -2.8% | 15,930 | +13.0% | 0.64% | -0.9% |
Q1 2018 | $745,000 | -26.6% | 14,103 | -5.5% | 0.65% | -49.3% |
Q4 2017 | $1,015,000 | -24.6% | 14,929 | -8.7% | 1.27% | +600.0% |
Q3 2017 | $1,347,000 | -12.0% | 16,349 | 0.0% | 0.18% | -20.5% |
Q2 2017 | $1,531,000 | +208.7% | 16,349 | +109.7% | 0.23% | +160.2% |
Q1 2017 | $496,000 | +58.5% | 7,797 | +10.5% | 0.09% | -5.4% |
Q4 2016 | $313,000 | -51.4% | 7,054 | -60.5% | 0.09% | -70.1% |
Q3 2016 | $644,000 | +162.9% | 17,865 | 0.0% | 0.31% | +70.9% |
Q2 2016 | $245,000 | +70.1% | 17,865 | +137.4% | 0.18% | -8.1% |
Q1 2016 | $144,000 | -48.6% | 7,526 | -5.9% | 0.20% | -74.3% |
Q4 2015 | $280,000 | – | 7,999 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |